Abstract:Background: Amyloidoses are characterized by the extracellular deposition of insoluble fibrillar proteinaceous aggregates highly organized into cross-β structure and referred to as amyloid fibrils. Nowadays, the diagnosis of these diseases remains tedious and involves multiple examinations while an early and accurate protein typing is crucial for the patients' treatment. Routinely used neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) using Pittsburgh compound B, [(11)C]PIB, provide structural information and allow to assess the amyloid burden, respectively, but cannot discriminate between different amyloid deposits. Therefore, the availability of efficient multimodal imaging nanoparticles targeting specific amyloid fibrils would provide a minimally-invasive imaging tool useful for amyloidoses typing and early diagnosis. In the present study, we have functionalized gadolinium-based MRI nanoparticles (AGuIX) with peptides highly specific for Aβ amyloid fibrils, LPFFD and KLVFF. The capacity of such nanoparticles grafted with peptide to discriminate among different amyloid proteins, was tested with Aβ(1-42) fibrils and with mutated-(V30M) transthyretin (TTR) fibrils. Results: The results of surface plasmon resonance studies showed that both functionalized nanoparticles interact with Aβ(1-42) fibrils with equilibrium dissociation constant (Kd) values of 403 and 350 µM respectively, whilst they did not interact with V30M-TTR fibrils. Similar experiments, performed with PIB, displayed an interaction both with Aβ(1-42) fibrils and V30M-TTR fibrils, with Kd values of 6 and 10 µM respectively, confirming this agent as a general amyloid fibril marker. Thereafter, the ability of functionalized nanoparticle to target and bind selectively Aβ aggregates was further investigated by immunohistochemistry on AD like-neuropathology brain tissue. Pictures clearly indicated that KLVFF-grafted or LPFFD-grafted to AGuIX nanoparticle recognized and bound the Aβ amyloid plaque localized in the mouse hippocampus. Conclusion: These results constitute a first step for considering these functionalized nanoparticles as a valuable multimodal imaging tool to selectively discriminate and diagnose amyloidoses.

Fibril Paint: a class of amyloid-targeting peptides

FibrilPaint targets amyloid fibrils for ubiquitination

An efficient biochemical method for characterizing and classifying potentially amyloidogenic and therapeutic peptides

Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting

Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.

A hyperbranched dopamine-containing PEG-based polymer for the inhibition of α-synuclein fibrillation.

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Design of amyloidogenic peptide traps

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

Cyclic peptides as inhibitors of amyloid fibrillation.

Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands.

De novo Design of Peptides that Bind Specific Conformers of α-Synuclein

Advances in Alzheimer's Disease-Associated Aβ Therapy Based on Peptide

Structural mechanism for specific binding of chemical compounds to amyloid fibrils

Highly tunable bimane-based fluorescent probes: design, synthesis, and application as a selective amyloid binding dye

Probing Alzheimer's pathology: Exploring the next generation of FDDNP analogues for amyloid β detection

Peptides for Disrupting and Degrading Amyloids.

Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation

Exploring the Aβ1-42 fibrillogenesis timeline by atomic force microscopy and surface enhanced Raman spectroscopy

Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface